Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01791478
Title BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors Vanderbilt-Ingram Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

Alpelisib + Letrozole

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST